Kelly Douglas E

Avg. Two Year Performance

(61%) Avg. Purchase Return
(27%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return12%(17%)(21%)(36%)(61%)
Purchase Success Rate2 of 32 of 30 of 31 of 30 of 3
Average Sale Return----------
Sale Success Rate----------
Drugs » Biotechnology

Director, 10% Owner:

Holdings: 4.29M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Computer Software & Svcs » Business Software & Services

Director:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--